Novartis
chinooktx.com
Actively hiring
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
CAS announces collaboration with Novartis to advance AI-ready reaction informatics
media1238833Researchers will gain an integrated synthetic data foundation and an advanced custom search platform to support reaction data discovery and analysis
Read more
Report
3 steps for taking on Novartis in radiopharma: Curium up first
To successfully challenge Novartis on two planned fronts, Curium will need to overcome the unique challenges posed by radiopharmaceutical supply to get products to patients and win market share.
Read more
Report
A Top Novartis (NVS) Shareholder Says 'The Party is Over' for its Dealmaking Team
On September 10, 2026, Reuters reported that Artisan Partners, among Novartis AG (NYSE:NVS)' 20 largest shareholders, publicly called for a shake-up of the Swiss drugmaker's board to improve oversight of its acquisitions, after Novartis shares suffered an
Read more
Report
Novartis (NVS) Faces Another Pipeline Setback as ALS Drug Fails Mid-Stage Trial
Novartis AG (NYSE:NVS) has discontinued development of VHB937, also known as lifonebart, after the experimental ALS drug failed to meet both its primary and secondary endpoints in a Phase II trial involving 251 patients with early-stage ALS. The drug targ
Read more
Report
Novartis, Novo Nordisk drug failures will likely 'pop a hole in the balloon' of the field
One expert said that after a resurgence in cardiovascular trials, investments in the space will be harder to come by.
Read more
Report
Show more news